Evidence map›Paper›PMID 29567770›Full record

ArticleHaematologica2018

Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.

Stéphanie Gon, Marie Loosveld, Thomas Crouzet, Delphine Potier, Mélanie Bonnet, Stéphanie O Morin, Gérard Michel, Norbert Vey, Jacques A Nunès, Bernard Malissen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Stéphanie GonAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Marie LoosveldAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Thomas CrouzetAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Delphine PotierAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Mélanie BonnetAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Stéphanie O MorinAix-Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.
Gérard MichelAPHM, Hôpital La Timone, Service d'Hématologie et d'Oncologie Pédiatrique, Marseille, France.
Norbert VeyAix-Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.
Jacques A NunèsAix-Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.
Bernard MalissenAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Romain RoncagalliAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Bertrand NadelAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France payet@ciml.univ-mrs.fr nadel@ciml.univ-mrs.fr.
Dominique Payet-BornetAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France payet@ciml.univ-mrs.fr nadel@ciml.univ-mrs.fr.
Aix-Marseille Université · FRCentre National de la Recherche Scientifique · FRInserm · FRHôpital de la Timone · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signaling through the αβT cell receptor (TCR) is a crucial determinant of T-cell fate and can induce two opposite outcomes during thymocyte development: cell death or survival and differentiation. To date, the role played by T-cell receptor in the oncogenic transformation of developing T cells remains unclear. Here we show that human primary T-cell acute lymphoblastic leukemias expressing an αβT cell receptor are frequently deficient for phosphatase and tensin homolog protein (PTEN), and fail to respond strongly to T-cell receptor activation. Using Pten-deficient T-cell acute lymphoblastic leukemia mouse models, we confirm that T-cell receptor signaling is involved in leukemogenesis. We show that abrogation of T-cell receptor expression accelerated tumor onset, while enforced expression of a fit transgenic T-cell receptor led to the development of T-cell receptor-negative lymphoma and delayed tumorigenesis. We further demonstrate that pre-tumoral Pten-deficient thymocytes harboring fit T-cell receptors undergo early clonal deletion, thus preventing their malignant transformation, while cells with unfit T-cell receptors that should normally be deleted during positive selection, pass selection and develop T-cell acute lymphoblastic leukemias. Altogether, our data show that fit T-cell receptor signaling suppresses tumor development mediated by Pten loss-of-function and point towards a role of Pten in positive selection.

Indexed as

AnimalsApoptosisBiomarkers, TumorCell DifferentiationCell Transformation, NeoplasticDisease Models, AnimalHumansLeukemiaMiceMice, TransgenicPTEN PhosphohydrolaseReceptors, Antigen, T-Cell, alpha-betaSignal TransductionThymocytesBiomarkers, TumorPTEN PhosphohydrolasePTEN protein, humanReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID29567770
PMCPMC6058769
OpenAlexW2791366301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.